Home/Filings/4/0001437749-23-004866
4//SEC Filing

Nussbaum Ran 4

Accession 0001437749-23-004866

CIK 0001668243other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 12:21 PM ET

Size

6.4 KB

Accession

0001437749-23-004866

Insider Transaction Report

Form 4
Period: 2022-06-16
Nussbaum Ran
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2022-06-16$5.00/sh+2,211$11,0551,437,169 total(indirect: Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd.)
  • Exercise/Conversion

    Stock Option (right to buy)

    2022-06-162,2110 total(indirect: By Partnership)
    Exercise: $5.00From: 2015-09-01Exp: 2022-09-01Ordinary Shares (2,211 underlying)

Issuer

UroGen Pharma Ltd.

CIK 0001668243

Entity typeother

Related Parties

1
  • filerCIK 0001609805

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 12:21 PM ET
Size
6.4 KB